Effect of the TEGO Connector in Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and/or Bacteremia
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The aim of the trial was to assess whether use of the TEGO connector was able to reduce the
incidence of a composite endpoint of TCC-related dysfunction (TCC-D)or TCC-related bacteremia
(TCC-B) in chronic hemodialysis (HD) patients carrying the TEGO® connector vs controls
receiving trisodium citrate 46.7%.